A generative AI system can now analyze blood cells with greater accuracy and confidence than human experts, detecting subtle signs of diseases like leukemia. It not only spots rare abnormalities but ...
The leading Chronic Myeloid Leukemia Companies such as Kartos Therapeutics, AOP Orphan Pharmaceuticals, Biokine Therapeutics, ...
Gertrude B. Elion, a chemist working in the research laboratories of Burroughs Wellcome, revolutionized childhood cancer ...
A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in ...
Amgen acquires Dark Blue Therapeutics for up to $840 million, adding early-stage leukemia drug research and strengthening its oncology discovery pipeline.
New immune roadmaps help physicians detect cancer recurrence early and customize treatments to the body’s defenses, providing ...
News-Medical.Net on MSN
Immune cell atlas may improve survival predictions, guide treatment decisions in multiple myeloma
aps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma ...
New research provides a mechanistic map of how genetic mutations disrupt RNA splicing in acute myeloid leukemia.
Researchers at WashU Medicine and their collaborators have created an immune cell atlas of multiple myeloma, a cancer of the ...
Researchers at WashU Medicine and their collaborators have created an immune cell atlas of multiple myeloma, a cancer of the ...
A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback